Leadership Overview
IntegriChain has 4 executives leading key functions including strategy, finance, technology, and operations.
Driven by innovation, IntegriChain provides the data and business process platform essential for therapy commercialization and market access, empowering pharmaceutical manufacturers to navigate complex payer contracting, patient services, and distribution channels with advanced data integration and strategic expertise.
Driven by innovation, IntegriChain provides the data and business process platform essential for therapy commercialization and market access, empowering pharmaceutical manufacturers to navigate complex payer contracting, patient services, and distribution channels with advanced data integration and strategic expertise.
Leadership Roles at IntegriChain
Joshua Halpern - Co-Founder & Chief Executive Officer
Joshua Halpern, the Co-Founder & Chief Executive Officer at IntegriChain, directs the overarching strategy and vision for the company's data and business process platform. Halpern guides the organization's efforts in therapy commercialization and market access, ensuring manufacturers receive the necessary infrastructure for success. This leadership involves defining the strategic roadmap for the ICyte Platform, which unites critical financial, operational, and commercial data sets. By focusing on the unique demands of specialty and precision medicine, Joshua Halpern enables pharmaceutical innovators to digitalize market access operations. This digitalization frees up resources, allowing for a greater emphasis on data-driven decision support and ultimately enhancing the efficiency and effectiveness of therapy access.
Matthew Heyman - Chief Financial Officer
Matthew Heyman, the Chief Financial Officer at IntegriChain, manages the company's financial operations and strategic fiscal planning. Heyman oversees all financial aspects supporting the ICyte Platform and the broader business process infrastructure for therapy commercialization. This role involves ensuring robust financial controls and driving financial strategies that align with IntegriChain's mission to empower pharmaceutical manufacturers. Matthew Heyman's expertise is critical in optimizing the financial models for market access and therapy commercialization, particularly within the complex landscape of specialty and precision medicine. By providing clear financial insights, Heyman supports the company's ability to offer data-driven decision support and maintain a strong market position.
Sean Downey - Chief Operating Officer
Sean Downey, the Chief Operating Officer at IntegriChain, directs the operational execution of the company's data and business process platform, ensuring seamless delivery of services for therapy commercialization and market access. Downey oversees the business process infrastructure, managing the day-to-day operations that support pharmaceutical manufacturers in their contracting, patient services, and distribution channel management. This critical role ensures the ICyte Platform functions efficiently, uniting the financial, operational, and commercial data required for effective therapy access. Sean Downey's operational leadership is vital for enabling pharmaceutical innovators to digitalize their market access operations, thereby enhancing data-driven decision support and optimizing the commercialization of specialty and precision medicines.
Bradley Burget - Chief Technology Officer
Bradley Burget, the Chief Technology Officer at IntegriChain, architects and oversees the technological infrastructure powering the company's data and business process platform. Burget leads the development and enhancement of the ICyte Platform, ensuring its capability to integrate diverse financial, operational, and commercial data sets essential for therapy access. This leadership is crucial for supporting market access and therapy commercialization strategies for pharmaceutical manufacturers. Bradley Burget's focus on technological innovation enables the digitalization of market access operations, a key component in the era of specialty and precision medicine. By driving technological advancements, Burget ensures the platform provides robust data-driven decision support, freeing up resources for clients to concentrate on strategic outcomes.
Explore Leadership Teams in Healthcare Software
Omnicell is a global healthcare technology company founded in 1992 that specializes in medication and supply management solutions. The company provides automation systems, software, and services that help healthcare organizations improve patient safety, operational efficiency, and regulatory compliance. Omnicell's product portfolio includes automated dispensing cabinets, analytics platforms, medication adherence solutions, robotic dispensing systems, and supply management technologies. These solutions are designed to reduce medication errors, streamline workflows, and optimize inventory management across various healthcare settings including hospitals, retail pharmacies, and long-term care facilities. Omnicell's technology integrates with hospital information systems to create a comprehensive medication management ecosystem that supports healthcare providers worldwide.
Company Leadership
SP
LR
Medidata Solutions is a platform that allows customers to create products and services using virtual experiences to help generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies. The company is based in New York, NY and is a Dassault Systems company.
Company Leadership JS
JS
TS
Convey Health Solutions, founded in 2001 and headquartered in Fort Lauderdale, Florida, provides healthcare technology solutions. The Company offline enrollment processing, enrollment processing, telephonic licensed enrollment, outbound campaigns, pharmacy and clinical, healthcare analytics, risk adjustment, and administration solutions.
Company Leadership
GA
SP
HealthMark Group is a leading provider of software and technology-enabled health information management solutions for healthcare providers across the country. By leveraging technology to reimagine the business of healthcare, HealthMark transforms administrative processes into seamless digital solutions. From patient intake technology supported by OTech, to HealthMark's proprietary MedRelease platform for Release of Information, the company is pioneering an efficient, compliant, and patient-centric approach to support the entire spectrum of the patient information journey. HealthMark Group was founded in 2006 with corporate headquarters in Dallas, TX and has been named to both the Dallas 100 and the Inc. 5000 for multiple years in a row as one of the fastest growing companies in the region and in the country.
Company Leadership GL
Frequently Asked Questions Regarding IntegriChain Top Executives and Leadership Team
